Adagene (ADAG) Current Leases (2022 - 2026)
Adagene (ADAG) posted quarterly Current Leases of $92.1 billion for Q4 2025, down 34.87% year-over-year from $141.3 billion in Q4 2024, and up 73145921.88% quarter-over-quarter from $125851.0 in Q2 2025.
Analysis
Adagene (ADAG) Current Leases (2022 - 2026) Analysis & Trends
Adagene (ADAG) has reported Current Leases for 4 consecutive years, with $92.1 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases fell 34.87% year-over-year to $92.1 billion; the TTM figure through Dec 2025 stood at $92.1 billion (down 34.87% YoY), while the FY2025 annual figure was $92.1 billion, down 34.87% from the prior year.
- Current Leases advanced to $92.1 billion in Q4 2025 per ADAG's latest filing, from $125851.0 in the prior quarter.
- Across five years, Current Leases topped out at $297.1 billion in Q2 2022 and bottomed at $125851.0 in Q2 2025.
- Historically, Current Leases has averaged $129.7 billion across 4 years, with a median of $146.7 billion in 2022.
- Annual changes were most pronounced in 2023 — Current Leases increased 28.93% — and 2024, when it plunged 100.0%.
- Adagene's Current Leases stood at $152.0 billion in 2022, then climbed by 28.93% to $196.0 billion in 2023, then declined by 27.87% to $141.3 billion in 2024, then sank by 34.87% to $92.1 billion in 2025.
- Business Quant data shows ADAG's Current Leases at $92.1 billion in Q4 2025, $125851.0 in Q2 2025, and $141.3 billion in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Adagene | 211.24 Mn | 211.24 Mn | - | 181,733.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 181,733.00 |
| Dec 31, 2025 | 92,055.00 |
| Jun 30, 2025 | 125,851.00 |
| Dec 31, 2024 | 141,341.00 |
| Jun 30, 2024 | 141,281.00 |
| Dec 31, 2023 | 195,955.00 |
| Jun 30, 2023 | 158,859.00 |
| Dec 31, 2022 | 151,983.00 |
| Jun 30, 2022 | 297,066.00 |